At a glance
ClinicalIndex Comparison RecordN/ACompleted· 106 enrolled
Drug / intervention
TESS V2device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective and Prospective, Multi Centre Study on T.E.S.S® V2 Shoulder System
In Brief
An observational study evaluating TESS V2 for Osteoarthritis Shoulder and 5 related conditions. Completed, enrolled 106 participants across 2 sites in 2 countries.
Detailed Summary
This study is a Post Market Clinical Follow-up study to fulfill the post market surveillance requirements. The data collected from this study will serve the purpose of confirming safety and performance of the TESS Shoulder System.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis Shoulder, Fracture, Rheumatoid Arthritis, Avascular Necrosis, Rotator Cuff Tear, Revision
CountriesBelgium, France
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2010
Primary CompletionDec 2015
First PostedFeb 2018
Study CompletionDec 2019
TodayJul 2026
First PostedFeb 13, 2018
Enrollment StartOct 20, 2010
Primary CompletionDec 31, 2015
Study CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 8.4 years ago
Interventions
TESS V2device
Patients requiring the TESS V2 prosthesis.